CD19-positive lymphocyte count is critical for acquisition of anti-SARS-CoV-2 IgG after vaccination in B-cell lymphoma

Affiliations

• ¹ Department of Hematology, Fujita Health University School of Medicine, Toyoake, Japan.
• ² Department of Advanced Diagnostic System Development, Fujita Health University Graduate School of Health Sciences, Toyoake, Japan.
• ³ International Center for Cell and Gene Therapy, Fujita Health University, Toyoake, Japan.
• ⁴ Department of Clinical Medicine, Fujita Health University School of Medicine, Toyoake, Japan.
• ⁵ Department of Transfusion Medicine and Cell Therapy, Fujita Health University Hospital, Toyoake, Japan.
• ⁶ Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
• ⁷ Department of Biochemical and Sciences, Chubu University, Kasugai, Japan.
• ⁸ Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
• ⁹ Department of Hematology, Gifu Municipal Hospital, Gifu, Japan.
• ¹⁰ Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan.
• ¹¹ Department of Clinical Laboratory, Fujita Health University Hospital, Toyoake, Japan; and.
• ¹² Department of Oncology, Fujita Health University Okazaki Medical Center, Okazaki, Japan.